For generations, medicine held that higher HDL cholesterol meant a safer heart — a reassuring equation that shaped clinical advice and drove pharmaceutical ambition. A large study drawing on nearly half a million UK Biobank participants now complicates that story, finding that men with very high HDL levels face nearly double the risk of cardiovascular and all-cause death, while women with the same elevated levels show no such penalty. The findings suggest that cholesterol, like most things in biology, resists simple arithmetic — and that the meaning of a number depends deeply on the body in wh
News-Medical.net
· May 23, 2023
· health
· 4 min de lectura
High
Verificación: Verificado
Study challenges 'good cholesterol' myth: very high HDL-C linked to mortality risk in men
◉
Science & Space
6944 artículos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% coincidencia
NASA Plans to Study Crater From SpaceX Rocket Collision With Moon
Gadgets 360 · 99% coincidencia
SpaceX Rocket Booster Set to Crash Into Moon in March
BOL News · 99% coincidencia
Chinese Rocket, Not SpaceX, Set to Strike Moon in March
CNET · 99% coincidencia
Artemis 2028 Mission May Unlock Lunar Mantle Secrets in Moon's Largest…
Google News · 99% coincidencia
Cobertura Relacionada
The Guardian · Aug 23
British firm trafficked enslaved Africans 40 years after abolition, letter reveals
Evidence reveals Sandbach, Tinne and Company illegally trafficked enslaved Africans to Guyana in 1847, four decades afte…
Space Daily · Aug 23 Webb finds Neptune's upper atmosphere far colder than Voyager measured 34 years agoWebb's 2023 observations reveal Neptune's upper atmosphere is 358K, far colder than Voyager 2's 1989 measurement of 750K…
Science Daily · Aug 23 Fast-spinning stars survive black hole encounters, revealing why their flares fadeAstronomers discovered that stars with rapid pre-existing rotation survive repeated close encounters with supermassive b…
Indian Aerospace and Defence Bulletin · Aug 23 India Charts Course for Sustainable Space Operations Amid Orbital Debris CrisisIndia launches initiatives to prevent orbital debris and establish sustainable space operations, including ISRO's Debris…
Sesgo y Encuadre
⚖
Article presents research findings with scientific framing but uses 'myth' language that may oversimplify complex cholesterol science; generally balanced but lacks counterargument perspectives.
Bias Direction
center
Confidence
MED
Challenge-to-conventional-wisdom framing using 'myth' terminology to emphasize novelty of findings; presents research as definitive despite nuanced gender-specific results
challenges 'good cholesterol' myth
very high HDL-C linked to mortality risk
assumption that higher HDL is always protective
Cardiologists or medical professionals defending the traditional HDL-C guidance
Discussion of why this finding contradicts decades of cardiovascular research
Limitations of the study or reasons for gender-specific differences
Clinical implications and whether guidelines should change based on single study
Perspectives from researchers who maintain HDL-C remains protective at these levels
Impacto Geopolítico
🌎
Medical research finding on cholesterol metabolism has no direct geopolitical implications; this is a health science study without international relations significance.
Escalation Risk
low
Confidence
HIGH
Lente Económico
📈
Research challenges 'good cholesterol' myth: very high HDL levels (>80 mg/100ml) linked to increased cardiovascular mortality in men, potentially disrupting cholesterol management practices and pharmaceutical strategies.
Market Signal
bearish
Confidence
MED
Pharmaceutical/Biotech (statin and HDL-raising drug manufacturers)
Healthcare/Medical Services
Diagnostic Testing/Laboratory Services
Health Insurance
Wellness/Preventive Health Industry
Consumers may experience confusion about cholesterol management goals; potential reduction in demand for HDL-raising medications and supplements; increased healthcare costs from additional testing to determine individual risk profiles; possible changes in preventive health recommendations affecting insurance premiums and out-of-pocket costs.
Regulatory bodies (FDA, EMA) may require updated clinical guidelines for cholesterol management with gender-specific thresholds; potential reassessment of pharmaceutical approvals for HDL-raising drugs; insurance coverage policies may shift; medical education standards may need revision; public health messaging on cholesterol will require clarification.